Drugs / BI 3923948
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07395258 | Apr 2026 → Feb 2028 | cancer | Boehringer Ingelheim | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 3923948 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07395258 ↗ |
| Route | Other | “BI 3923948 is given as injection(s) into the tumor” NCT07395258 ↗ |